IQVIA HOLDINGS INC. Accumulated Other Comprehensive Income
IQVIA HOLDINGS INC. (IQV) had Accumulated Other Comprehensive Income of -$968.00 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-05-05
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$968.00M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$943.00M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$928.00M.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$882.00M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-03-31 | -$968.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$943.00M 10-Q · filed 2026-05-05 | |
| 2025-09-30 | -$928.00M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | -$882.00M 10-Q · filed 2025-07-22 | |
| 2025-03-31 | -$978.00M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | -$1.04B 10-K · filed 2026-02-17 | |
| 2024-09-30 | -$826.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$949.00M 10-Q · filed 2024-07-22 | |
| 2024-03-31 | -$911.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | -$867.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | -$903.00M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | -$760.00M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | -$731.00M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | -$727.00M 10-K · filed 2024-02-15 | |
| 2022-09-30 | -$898.00M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | -$697.00M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | -$419.00M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | -$406.00M 10-K · filed 2023-02-15 | |
| 2021-09-30 | -$445.00M 10-Q · filed 2021-10-22 | |
| 2021-06-30 | -$327.00M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | -$376.00M 10-Q · filed 2021-04-23 | |
| 2020-12-31 | -$205.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | -$317.00M 10-Q · filed 2020-10-22 | |
| 2020-06-30 | -$444.00M 10-Q · filed 2020-07-23 | |
| 2020-03-31 | -$485.00M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | -$311.00M 10-K · filed 2021-02-12 | |
| 2019-09-30 | -$377.00M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | -$215.00M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | -$262.00M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | -$224.00M 10-K · filed 2020-02-18 | |
| 2018-09-30 | -$220.00M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | -$104.00M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $254.00M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $49.00M 10-K · filed 2019-02-19 | $46.00M 10-K · filed 2018-02-16 |
| 2017-09-30 | -$79.00M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | -$233.00M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | -$444.00M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$570.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | -$140.98M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | -$139.09M 10-Q · filed 2016-07-27 | |
| 2016-03-31 | -$105.76M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$111.00M 10-K · filed 2017-02-16 | -$111.37M 10-K · filed 2016-02-11 |
| 2015-09-30 | -$95.46M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | -$68.84M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | -$88.95M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | -$59.09M 10-K · filed 2016-02-11 | |
| 2014-09-30 | -$27.05M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.24M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | -$393.00K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | -$376.00K 10-K · filed 2015-02-12 | |
| 2013-09-30 | -$3.89M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | -$18.19M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$8.39M 10-Q · filed 2014-05-01 | |
| 2012-12-31 | $7.70M 10-K · filed 2015-02-12 | |
| 2012-09-30 | $16.85M 10-Q · filed 2013-10-31 | |
| 2011-12-31 | $22.87M 10-K · filed 2015-02-12 | |
| 2010-12-31 | $45.58M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |